Search results for " Rating"

showing 10 items of 529 documents

Consistencies and discrepancies in self- and observer-rated anxiety scales. A comparison between the self- and observer-rated Marks-Sheehan scales.

1990

The Marks-Sheehan anxiety scales are the only scales where self-ratings and observer ratings are perfectly matched by the number, the content and the scaling of the items. Therefore these scales are an excellent tool to investigate the compatibility and to study different structures in self- and observer ratings. This was done by using the data material on the Marks-Sheehan scales of the Cross National Collaborative Panic Study. In this study 1168 outpatients who met the DSM-III criteria for panic disorder were randomly allocated either to alprazolam, imipramine or placebo treatment. Our results show that the Marks-Sheehan scales are highly comparable to other established rating scales. Bot…

AdultPersonality TestsImipraminePersonality Assessmentbehavioral disciplines and activitiesDouble-Blind MethodRating scalemedicineHumansPharmacology (medical)Biological PsychiatryAlprazolamGeneral NeurosciencePanic disorderSelfBehaviorally anchored rating scalesPanicGeneral MedicineMiddle Agedmedicine.diseaseAnxiety DisordersPanicObserver ratingPsychiatry and Mental healthNeuropsychology and Physiological PsychologyAlprazolamAnxietymedicine.symptomPsychologySocial psychologymedicine.drugClinical psychologyEuropean archives of psychiatry and clinical neuroscience
researchProduct

Prediction of Course in Major Depression. Does Psychopathology Predict Future Drug Intake or Relapse?

1988

AdultPsychiatric Status Rating ScalesDepressive Disordermedicine.medical_specialtybusiness.industryGeneral MedicineMiddle AgedPrognosisPsychiatry and Mental healthRecurrencemedicineHumansPharmacology (medical)Drug intoxicationPsychiatrybusinessDepression (differential diagnoses)Clinical psychologyPsychopathologyPharmacopsychiatry
researchProduct

Psychopathological predictors of suicide in patients with major depression during a 5-year follow-up.

2001

SummaryObjective. It is widely known that the risk of suicide is higher in cases of major depressive disorders in comparison to the general population. The purpose of this study was to examine which psychopathologic symptoms during the index episode are predictors for an increased risk of suicide in the further course of major depression.Method. Mortality data were determined from a prospective study of 280 patients with major depression (DSM-III-R, single episode or recurrent) during a follow-up period of 5 years. The predictive power of different depressive symptoms including psychotic symptoms for suicide risk was investigated.Results.Patients who committed suicide(N = 16)during the foll…

Adultmedicine.medical_specialtyAdolescentPopulationPoison controlPsychotic depressionSuicide AttemptedSuicide prevention03 medical and health sciences0302 clinical medicinePredictive Value of TestsmedicineHumans030212 general & internal medicineProspective StudiesRisk factorPsychiatryeducationDepression (differential diagnoses)AgedAged 80 and overPsychiatric Status Rating Scaleseducation.field_of_studyDepressive Disorder MajorSuicide attemptMiddle Agedmedicine.disease030227 psychiatryPsychiatry and Mental healthPsychotic DisordersPsychologyPsychopathologyClinical psychologyFollow-Up StudiesEuropean psychiatry : the journal of the Association of European Psychiatrists
researchProduct

Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations

2001

The prevalence and pattern of cognitive impairment in systemic lupus erythematosus (SLE) patients with (NPSLE) and without (nSLE) overt neuropsychiatric manifestations were investigated. Fifty-two nSLE patients, 23 NPSLE patients and 27 healthy controls were evaluated with a battery of standardized neuropsychological and psychological tests. Disease duration, disease activity index, and current corticosteroid therapy were collected. Cognitive impairment was identified in 14 (26.9%) and in 12 (52.2%) of subjects with nSLE and NPSLE, respectively. Both SLE groups showed a significant impairment compared with controls on tasks assessing verbal and non-verbal long-term memory, and visuoconstruc…

Adultmedicine.medical_specialtyAnxietyNeuropsychological TestsMental ProcessesAdrenal Cortex HormonesMemoryInternal medicinemedicineHumansLupus Erythematosus SystemicSpeechSystemic lupus erythematosus Neuropsychiatric SLE Cognitive impairment Neuropsychology DepressionAttentionPsychological testingEffects of sleep deprivation on cognitive performanceDepression (differential diagnoses)Psychiatric Status Rating ScalesLupus erythematosusDepressionCognitive disorderNeuropsychologymedicine.diseaseConnective tissue diseaseMemory Short-TermNeurologyMental RecallPhysical therapyFemaleSettore MED/26 - NeurologiaNeurology (clinical)Cognition DisordersPsychologyPsychomotor PerformancePsychopathologyJournal of the Neurological Sciences
researchProduct

Changes in sexual function and quality of life after single-incision mid-urethral sling for treatment of female stress urinary incontinence.

2013

Abstract Objectives To evaluate the effectiveness and assess the changes in sexual function and quality of life after placement of a single-incision sling for the treatment of female stress urinary incontinence. Study design A prospective study of women diagnosed with stress urinary incontinence. The single-incision sling was implanted and patients were followed postoperatively for 6 months. The postoperative rate of continence, complications, changes in sexual function, and patient-reported quality of life were evaluated. Female Sexual Function in sexually active patients was evaluated before and after the single-incision sling procedure using the Female Sexual Function Index. From January…

Adultmedicine.medical_specialtySling (implant)Urinary Incontinence StressUrologyUrinary incontinenceSeverity of Illness IndexPatient satisfactionPostoperative ComplicationsQuality of lifeCost of IllnessGermanySeverity of illnessMedicineHumansProspective StudiesSexual Dysfunctions PsychologicalProspective cohort studyAgedPsychiatric Status Rating ScalesSuburethral Slingsbusiness.industryObstetrics and GynecologyMiddle AgedSurgeryPostmenopauseSexual Dysfunction PhysiologicalReproductive MedicinePremenopausePatient SatisfactionQuality of LifeFemaleImplantmedicine.symptombusinessSexual functionFollow-Up StudiesEuropean journal of obstetrics, gynecology, and reproductive biology
researchProduct

Treating Cockroach Phobia With Augmented Reality

2009

In vivo exposure is the recommended treatment of choice for specific phobias; however, it demonstrates a high attrition rate and is not effective in all instances. The use of virtual reality (VR) has improved the acceptance of exposure treatments to some individuals. Augmented reality (AR) is a variation of VR wherein the user sees the real world augmented by virtual elements. The present study tests an AR system in the short (posttreatment) and long term (3, 6, and 12 months) for the treatment of cockroach phobia using a multiple baseline design across individuals (with 6 participants). The AR exposure therapy was applied using the "one-session treatment" guidelines developed by Öst, Salko…

Adultmedicine.medical_specialtyTime FactorsPsychotherapistmedicine.medical_treatmentExposure therapyCockroachesVirtual realityUser-Computer InterfaceYoung AdultPhysical medicine and rehabilitationSurveys and Questionnairesbiology.animalmedicineAnimalsHumansPsychiatric Status Rating ScalesCockroachAr systembiologymedicine.diseaseClinical PsychologyTreatment OutcomeMultiple baseline designPhobic DisordersFemaleAugmented realityPsychologyAfter treatmentAnxiety disorderFollow-Up StudiesBehavior Therapy
researchProduct

Maintenance of weight loss after obesity treatment: is continuous support necessary?

2002

Abstract Objective: This study examined outcome differences of 109 obese subjects, who participated in a 10-week cognitive-behavioral inpatient treatment followed by either a weight maintenance program or a follow-up period without professional support. Methods: Self-rated weight loss, eating behaviors, and general psychopathology were assessed several months before treatment, when subjects were admitted, at discharge, and at the 6-, 12-, and 18-month follow-ups. Structured interviews for mental disorders and eating pathology were conducted additionally. Results: The mean weight of the sample at baseline was 127 kg. Weight loss of the total sample amounted to 8.0 kg (6.3%) and was completel…

Adultmedicine.medical_specialtyTime Factorsmedicine.medical_treatmentExperimental and Cognitive PsychologySeverity of Illness IndexBody Mass IndexWeight lossSurveys and QuestionnairesWeight maintenanceWeight LossmedicineHumansObesityPsychiatric Status Rating ScalesCognitive Behavioral TherapyMental DisordersProfessional supportmedicine.diseaseObesityPsychiatry and Mental healthClinical PsychologyGeneral psychopathologyStructured interviewPhysical therapyCognitive therapyFemaleObese subjectsmedicine.symptomEnergy IntakePsychologyFollow-Up StudiesBehaviour Research and Therapy
researchProduct

The concept of major depression. III. Concurrent validity of six competing operational definitions for the clinical ICD-9 diagnosis.

1991

The comparative validity of six operational diagnoses of major depression was evaluated in 600 psychiatric inpatients using the independently assessed clinical ICD-9 diagnoses as a yardstick. Agreement with, and positive predictive value for the ICD-9 categories of pure (endogenous and psychogenic) depression served as validation criteria; sensitivity of major depression diagnoses for detecting ICD-9 bipolar depressions was additionally used for examining the adequacy of width, time and exclusion criteria of the competing operational definitions. Three essential results were found. First, the "old" diagnostic definitions of RDC and FDC are superior to all newer definitions because they defi…

Affective Disorders PsychoticBipolar DisorderPsychometricsNeurotic DisordersPsychometricsConcurrent validityMEDLINEValidityDiagnosis DifferentialPsychogenic diseaseHumansPharmacology (medical)Medical diagnosisBiological PsychiatryDepression (differential diagnoses)Psychiatric Status Rating ScalesDepressive DisorderOperational definitionGeneral NeuroscienceGeneral MedicineHospitalizationPsychiatry and Mental healthNeuropsychology and Physiological PsychologySchizophreniaSchizophrenic PsychologyPsychologyClinical psychologyEuropean archives of psychiatry and clinical neuroscience
researchProduct

Risk of drug-related falls among noninstitutionalized older adults

2017

To determine the number of drugs taken per day, which represents a risk factor for falls among noninstitutionalized older adults with a history of falls in the last year.This was a descriptive study that used random sampling and the following measurement instruments: the WHO questionnaire for the study of falls in older adults, gait scale and geriatric depression scale and gait and balance. Univariate and bivariate analysis, nonparametric chi-squared test, and binary logistic regression were performed using the SPSS statistical program version 21.0.214 individuals participated in the study. Those who took ≥ 4 drugs presented higher risk of falling, p=0.010 OR=4.034. The same was not true fo…

Aged 80 and overMalePsychiatric Status Rating ScalesDrug-Related Side Effects and Adverse ReactionsDepressionCross-Sectional StudiesLogistic ModelsPharmaceutical PreparationsRisk FactorsSurveys and QuestionnairesHumansAccidental FallsFemaleGaitGeriatric AssessmentPostural BalanceAged
researchProduct

Roxindole, a dopamine autoreceptor agonist, in the treatment of positive and negative schizophrenic symptoms

1994

Twenty schizophrenic inpatients with either predominantly positive or predominantly negative symptoms were treated with the dopamine autoreceptor agonist roxindole in prospective open clinical trials. There was no antipsychotic effect in the subgroup with positive symptoms, whereas the subgroup with negative symptoms, especially those with the residual type of schizophrenia, showed a moderate but significant 20% reduction in total scores on the Scale for the Assessment of Negative Symptoms.

Agonistmedicine.medical_specialtyPsychosismedicine.drug_classDopamine AgentsGastroenterologyReceptors Dopaminechemistry.chemical_compoundRoxindoleInternal medicinemental disordersSchizophrenic PsychologymedicineHumansProspective StudiesScale for the Assessment of Negative SymptomsPsychiatric Status Rating ScalesSchizophrenia ParanoidDose-Response Relationship Drugbusiness.industrymedicine.diseaseHospitalizationPsychiatry and Mental healthTreatment OutcomeEndocrinologychemistrySchizophreniaDopamine receptorSchizophreniaAutoreceptorSchizophrenic PsychologybusinessAmerican Journal of Psychiatry
researchProduct